Schiff branded sales grow behind Mega-D3 launch
This article was originally published in The Tan Sheet
Executive SummaryThe Schiff Mega-D3 supplement, combining vitamin D3 and resveratrol, rolls out to retail as the Salt Lake City firm reports continued strong sales of branded products, particularly its MegaRed Krill Oil. However, softness in the joint care category hit Schiff Nutrition International's Move Free supplements and its private label business continued to struggle during the firm's fiscal 2011 first quarter, Schiff reported Sept. 14. Though net sales rose 5.9 percent to $51.4 million during the June-August period, net income dipped 16 percent to $3.7 million. Schiff CEO Bruce Wood said higher consumer advertising spending caused selling and marketing expenses to jump 40 percent to $9.3 million. The firm also announced a 70 cents-per-share special cash dividend to be paid Oct. 26 to shareholders as of Sept. 23
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.